Symptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver Disease

Persons living with human immunodeficiency virus (HIV) are living longer; therefore, they are more likely to suffer significant morbidity due to potentially treatable liver diseases. Clinical evidence suggests that the growing number of individuals living with HIV and liver disease may have a poorer...

Full description

Saved in:
Bibliographic Details
Main Authors: Wendy A. Henderson, Angela C. Martino, Noriko Kitamura, Kevin H. Kim, Judith A. Erlen
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:AIDS Research and Treatment
Online Access:http://dx.doi.org/10.1155/2012/169645
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566544848125952
author Wendy A. Henderson
Angela C. Martino
Noriko Kitamura
Kevin H. Kim
Judith A. Erlen
author_facet Wendy A. Henderson
Angela C. Martino
Noriko Kitamura
Kevin H. Kim
Judith A. Erlen
author_sort Wendy A. Henderson
collection DOAJ
description Persons living with human immunodeficiency virus (HIV) are living longer; therefore, they are more likely to suffer significant morbidity due to potentially treatable liver diseases. Clinical evidence suggests that the growing number of individuals living with HIV and liver disease may have a poorer health-related quality of life (HRQOL) than persons living with HIV who do not have comorbid liver disease. Thus, this study examined the multiple components of HRQOL by testing Wilson and Cleary’s model in a sample of 532 individuals (305 persons with HIV and 227 persons living with HIV and liver disease) using structural equation modeling. The model components include biological/physiological factors (HIV viral load, CD4 counts), symptom status (Beck Depression Inventory II and the Medical Outcomes Study HIV Health Survey (MOS-HIV) mental function), functional status (missed appointments and MOS-HIV physical function), general health perceptions (perceived burden visual analogue scale and MOS-HIV health transition), and overall quality of life (QOL) (Satisfaction with Life Scale and MOS-HIV overall QOL). The Wilson and Cleary model was found to be useful in linking clinical indicators to patient-related outcomes. The findings provide the foundation for development and future testing of targeted biobehavioral nursing interventions to improve HRQOL in persons living with HIV and liver disease.
format Article
id doaj-art-720d9323295f4e4ba75649b48f60c8d6
institution Kabale University
issn 2090-1240
2090-1259
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series AIDS Research and Treatment
spelling doaj-art-720d9323295f4e4ba75649b48f60c8d62025-02-03T01:03:47ZengWileyAIDS Research and Treatment2090-12402090-12592012-01-01201210.1155/2012/169645169645Symptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver DiseaseWendy A. Henderson0Angela C. Martino1Noriko Kitamura2Kevin H. Kim3Judith A. Erlen4Biobehavioral Unit, National Institute of Nursing Research, National Institutes of Health, DHHS, 10 Center Drive, Room 2-1339, Bethesda, MD 20892, USABiobehavioral Unit, National Institute of Nursing Research, National Institutes of Health, DHHS, 10 Center Drive, Room 2-1339, Bethesda, MD 20892, USABiobehavioral Unit, National Institute of Nursing Research, National Institutes of Health, DHHS, 10 Center Drive, Room 2-1339, Bethesda, MD 20892, USASchool of Education, University of Pittsburgh, 5918 Wesley W. Posvar Hall, 230 South Bouquet Street, Pittsburgh, PA 15261, USADepartment of Health and Community Systems, School of Nursing, University of Pittsburgh, 415 Victoria Building, 3500 Victoria Street, Pittsburgh, PA 15261, USAPersons living with human immunodeficiency virus (HIV) are living longer; therefore, they are more likely to suffer significant morbidity due to potentially treatable liver diseases. Clinical evidence suggests that the growing number of individuals living with HIV and liver disease may have a poorer health-related quality of life (HRQOL) than persons living with HIV who do not have comorbid liver disease. Thus, this study examined the multiple components of HRQOL by testing Wilson and Cleary’s model in a sample of 532 individuals (305 persons with HIV and 227 persons living with HIV and liver disease) using structural equation modeling. The model components include biological/physiological factors (HIV viral load, CD4 counts), symptom status (Beck Depression Inventory II and the Medical Outcomes Study HIV Health Survey (MOS-HIV) mental function), functional status (missed appointments and MOS-HIV physical function), general health perceptions (perceived burden visual analogue scale and MOS-HIV health transition), and overall quality of life (QOL) (Satisfaction with Life Scale and MOS-HIV overall QOL). The Wilson and Cleary model was found to be useful in linking clinical indicators to patient-related outcomes. The findings provide the foundation for development and future testing of targeted biobehavioral nursing interventions to improve HRQOL in persons living with HIV and liver disease.http://dx.doi.org/10.1155/2012/169645
spellingShingle Wendy A. Henderson
Angela C. Martino
Noriko Kitamura
Kevin H. Kim
Judith A. Erlen
Symptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver Disease
AIDS Research and Treatment
title Symptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver Disease
title_full Symptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver Disease
title_fullStr Symptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver Disease
title_full_unstemmed Symptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver Disease
title_short Symptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver Disease
title_sort symptom status predicts patient outcomes in persons with hiv and comorbid liver disease
url http://dx.doi.org/10.1155/2012/169645
work_keys_str_mv AT wendyahenderson symptomstatuspredictspatientoutcomesinpersonswithhivandcomorbidliverdisease
AT angelacmartino symptomstatuspredictspatientoutcomesinpersonswithhivandcomorbidliverdisease
AT norikokitamura symptomstatuspredictspatientoutcomesinpersonswithhivandcomorbidliverdisease
AT kevinhkim symptomstatuspredictspatientoutcomesinpersonswithhivandcomorbidliverdisease
AT judithaerlen symptomstatuspredictspatientoutcomesinpersonswithhivandcomorbidliverdisease